Malaysia #6449 (v.3)
Base data
- Notified in
-
G/MA/QR/N/MYS/3 24/10/2023
- Version validity
-
24/10/2023 -
present
Current active version v.3
- Reporting member
- Malaysia
- In force from
- End date
- In force
- General description
-
Non-automatic licensing on the import of products for the purpose of clinical trials
- National legal basis
-
Sale of Drugs Act 1952 [Act 368]
Control of Drugs and Cosmetics Regulations 1984 - Administrative mechanism
-
Administered by Ministry of Health (MOH).
Details of the requirement on Malaysian Guideline for Application of Clinical Trial Import License and Clinical Trial Exemption can be accessed here:
https://www.npra.gov.my/easyarticles/images/users/1140/Malaysian-Guideline-for-Application-of-CTIL-and-CTX-7.1-Edition-16.09.2021.pdf - Responsible entities
-
Ministry of Health
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
XX:(a) - (a) necessary to protect public morals;
GATT 1994 (GATT 1947 provisions)
Reported as: Articles XX(a) and XX(b) of the GATTXX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Reported as: Articles XX(a) and XX(b) of the GATT - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- NAL
| Symbol |
|---|
|
NAL
|
Tariff lines
|
3001
|
3001
|
Products for the purpose of clinical trials
|
|
|
3002
|
3002
|
Products for the purpose of clinical trials
|
|
|
3003
|
3003
|
Products for the purpose of clinical trials
|
|
|
3004
|
3004
|
Products for the purpose of clinical trials
|
|
|
3005
|
3005
|
Products for the purpose of clinical trials
|
|